References

No references inside the corpus for this window.

Cited by

• 2005Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors231 cited
• 2011Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers230 cited
• 2022Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects225 cited
• 2010Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice213 cited
• 2017Effect of Psilocybin on Empathy and Moral Decision-Making197 cited
• 2017Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults188 cited
• 2003Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia187 cited
• 2020Psilocybin: from ancient magic to modern medicine186 cited
• 2021Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects184 cited
• 2021Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience152 cited
• 2007Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans146 cited
• 2016Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience